首页> 外文OA文献 >Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model
【2h】

Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model

机译:口服泛昔洛韦后喷昔洛韦的眼内渗透:群体药代动力学模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives We developed a population model that describes the ocular penetration and pharmacokinetics of penciclovir in human aqueous humour and plasma after oral administration of famciclovir. Methods Fifty-three patients undergoing cataract surgery received a single oral dose of 500 mg of famciclovir prior to surgery. Concentrations of penciclovir in both plasma and aqueous humour were measured by HPLC with fluorescence detection. Concentrations in plasma and aqueous humour were fitted using a two-compartment model (NONMEM software). Inter-individual and intra-individual variabilities were quantified and the influence of demographics and physiopathological and environmental variables on penciclovir pharmacokinetics was explored. Results Drug concentrations were fitted using a two-compartment, open model with first-order transfer rates between plasma and aqueous humour compartments. Among tested covariates, creatinine clearance, co-intake of angiotensin-converting enzyme inhibitors and body weight significantly influenced penciclovir pharmacokinetics. Plasma clearance was 22.8 ± 9.1 L/h and clearance from the aqueous humour was 8.2 × 10−5 L/h. AUCs were 25.4 ± 10.2 and 6.6 ± 1.8 μg · h/mL in plasma and aqueous humour, respectively, yielding a penetration ratio of 0.28 ± 0.06. Simulated concentrations in the aqueous humour after administration of 500 mg of famciclovir three times daily were in the range of values required for 50% growth inhibition of non-resistant strains of the herpes zoster virus family. Conclusions Plasma and aqueous penciclovir concentrations showed significant variability that could only be partially explained by renal function, body weight and comedication. Concentrations in the aqueous humour were much lower than in plasma, suggesting that factors in the blood-aqueous humour barrier might prevent its ocular penetration or that redistribution occurs in other ocular compartments
机译:目的我们建立了一个人口模型,用于描述泛昔洛韦口服后泛昔洛韦在人房水和血浆中的眼部渗透和药代动力学。方法53例接受白内障手术的患者在手术前接受单次口服口服泛昔洛韦500 mg。通过具有荧光检测的HPLC来测量血浆和房水中的喷昔洛韦浓度。使用两室模型(NONMEM软件)拟合血浆和房水中的浓度。量化个体间和个体内的变异性,并探讨人口统计学,生理病理学和环境变量对喷昔洛韦药代动力学的影响。结果使用两室开放模型拟合血浆和房水房之间的一级转移率,拟合药物浓度。在测试的协变量中,肌酐清除率,血管紧张素转化酶抑制剂的共同摄入和体重显着影响了喷昔洛韦的药代动力学。血浆清除率为22.8×±9.1L / h,与房水的清除率为8.2××10-5 L / h。在血浆和含水幽默物中,AUC分别为25.4±10.2和6.6±1.8μg·h / mL,渗透率为0.28±0.06。每天三次服用500 mg泛昔洛韦后,房水中的模拟浓度在带状疱疹病毒家族非耐药菌株50%生长抑制所需的数值范围内。结论血浆和喷昔洛韦水溶液的浓度显示出显着的变异性,只能由肾功能,体重和喜剧性部分解释。房水中的浓度远低于血浆中的浓度,这表明血水性液屏障中的因素可能阻止其眼部渗透或在其他眼部隔室中发生重新分布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号